MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4000
-0.0098
-2.39%
After Hours: 0.3900 -0.01 -2.50% 19:28 05/22 EDT
OPEN
0.4010
PREV CLOSE
0.4098
HIGH
0.4300
LOW
0.3800
VOLUME
231.83K
TURNOVER
--
52 WEEK HIGH
1.090
52 WEEK LOW
0.1900
MARKET CAP
21.56M
P/E (TTM)
-0.8571
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TLGT stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.

EPS

TLGT News

More
Teligent's (TLGT) CEO Tim Sawyer on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 3d ago
Teligent: Q1 Earnings Insights
Benzinga · 3d ago
Teligent, Inc. Announces First Quarter 2020 Results
GlobeNewswire · 3d ago
Teligent: Q1 Earnings Insights
Shares of Teligent (NASDAQ:TLGT) moved higher by 34% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 155.56% year over year to ($0.23), which missed the estimate of ($0.18).
Benzinga · 3d ago
Teligent Q1 EPS $(0.230) Misses $(0.180) Estimate, Sales $7.447M Miss $7.950M Estimate
Teligent (NASDAQ:TLGT) reported quarterly losses of $(0.230) per share which missed the analyst consensus estimate of $(0.180) by 27.78 percent. This is a 155.56 percent decrease over losses of $(0.090) per share from
Benzinga · 3d ago
Teligent, Inc. to Host Earnings Call
ACCESSWIRE · 3d ago
Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020
BUENA, N.J., May 19, 2020 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET.
GlobeNewswire · 6d ago
Edited Transcript of TLGT earnings conference call or presentation 8-Apr-20 12:00pm GMT
Thomson Reuters StreetEvents · 04/10 04:32

Industry

Pharmaceuticals
-0.29%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About TLGT

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
More

Webull offers kinds of Teligent Inc (NEW JERSEY) stock information, including NASDAQ:TLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLGT stock news, and many more online research tools to help you make informed decisions.